908 Devices Inc (NASDAQ: MASS) kicked off on Tuesday, up 95.96% from the previous trading day, before settling in for the closing price of $1.98. Over the past 52 weeks, MASS has traded in a range of $1.81-$7.56.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 31.20%. While this was happening, its average annual earnings per share was recorded 48.58%. With a float of $25.37 million, this company’s outstanding shares have now reached $34.71 million.
Let’s determine the extent of company efficiency that accounts for 230 employees. In terms of profitability, gross margin is 48.26%, operating margin of -119.93%, and the pretax margin is -109.5%.
908 Devices Inc (MASS) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of 908 Devices Inc is 27.15%, while institutional ownership is 44.78%. The most recent insider transaction that took place on Feb 03 ’25, was worth 23,985. In this transaction Chief Financial Officer of this company sold 10,236 shares at a rate of $2.34, taking the stock ownership to the 109,870 shares. Before that another transaction happened on Feb 03 ’25, when Company’s Chief Legal & Admin Officer sold 9,672 for $2.33, making the entire transaction worth $22,499. This insider now owns 24,603 shares in total.
908 Devices Inc (MASS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.58% per share during the next fiscal year.
908 Devices Inc (NASDAQ: MASS) Trading Performance Indicators
Take a look at 908 Devices Inc’s (MASS) current performance indicators. Last quarter, stock had a quick ratio of 3.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.78, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -0.92 in one year’s time.
Technical Analysis of 908 Devices Inc (MASS)
Looking closely at 908 Devices Inc (NASDAQ: MASS), its last 5-days average volume was 25.33 million, which is a jump from its year-to-date volume of 3.76 million. As of the previous 9 days, the stock’s Stochastic %D was 39.27%. Additionally, its Average True Range was 0.39.
During the past 100 days, 908 Devices Inc’s (MASS) raw stochastic average was set at 92.41%, which indicates a significant decrease from 94.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 296.44% in the past 14 days, which was higher than the 156.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4200, while its 200-day Moving Average is $3.7900. However, in the short run, 908 Devices Inc’s stock first resistance to watch stands at $4.2200. Second resistance stands at $4.5700. The third major resistance level sits at $5.1300. If the price goes on to break the first support level at $3.3100, it is likely to go to the next support level at $2.7500. Now, if the price goes above the second support level, the third support stands at $2.4000.
908 Devices Inc (NASDAQ: MASS) Key Stats
The company with the Market Capitalisation of 135.11 million has total of 34,823K Shares Outstanding. Its annual sales at the moment are 50,230 K in contrast with the sum of -36,400 K annual income. Company’s last quarter sales were recorded 16,770 K and last quarter income was -29,300 K.